CD4 T Cells and Their Role in Antitumor Immune Responses

This publication has 37 references indexed in Scilit:

• Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors
  The Journal of Experimental Medicine, 1998
• Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes.
  The Journal of Experimental Medicine, 1996
• Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
  Science, 1994
• A tumor escape variant that has lost one major histocompatibility complex class I restriction element induces specific CD8+ T cells to an antigen that no longer serves as a target.
  The Journal of Experimental Medicine, 1993
• Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes
  Cell, 1989
• Linked Recognition of Helper and Cytotoxic Antigenic Determinants for the Generation of Cytotoxic T Lymphocytes^a
  Annals of the New York Academy of Sciences, 1988
• CD4⁺ helper T cells are required for resistance to a highly metastatic murine tumor
  European Journal of Immunology, 1987
• Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.
  The Journal of Experimental Medicine, 1985
• Helper activity is required for the in vivo generation of cytotoxic T lymphocytes
  The Journal of Experimental Medicine, 1982
• Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay.
  The Journal of Experimental Medicine, 1976